MedTrace Logo

Treating Parents to Reduce NICU Transmission of Staphylococcus Aureus Trial

NCT02223520 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 307

Last updated 2022-01-11

Study results available
· View outcomes & findings →

Summary

This trial will test the hypothesis that treating parents of neonates requiring NICU care with intranasal mupirocin and topical chlorhexidine bathing will reduce the spread of S. aureus from parents to neonates.

Conditions

  • Staph Aureus Colonization
  • Staph Aureus Infection

Interventions

DRUG

Mupirocin and Chlorhexidine

DRUG

Placebo ointment and placebo cloths

Sponsors & Collaborators

Principal Investigators

  • Aaron Milstone, MD, MHS · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2019-10-31
Completion
2019-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02223520 on ClinicalTrials.gov